BioSpace News Archive

Innate Pharma to Participate in upcoming investor conferences - Nov 12, 2020

Innate Pharma SA, announced that members of its senior management team are scheduled to participate in the following upcoming virtual investor conferences.

November 12, 2020
·
4 min read
Business

Evotec SE Reports Results For the First Nine Months 2020 and Provides Corporate Update

Robust revenue growth in both segments: Total EVT Execute revenues up 14% to € 352.7 m (9M 2019: € 308.1 m); EVT Innovate revenues up 21% to € 74.7 m (9M 2019: € 61.8 m)

November 12, 2020
·
7 min read
Drug Development

Zhaoke Ophthalmology Announced First Patient Completes Three Year Enrollment in Phase III CHAMP Study of NVK-002

Zhaoke Ophthalmology Pharmaceutical Ltd. is pleased to announce that the first patient has completed three year enrollment in the Phase III CHAMP study carried out by its partner, Nevakar Inc.

November 12, 2020
·
4 min read
Evotec Expands Oxfordshire Site into a Fully-Integrated R&D Centre Named ‘Dorothy Crowfoot Hodgkin Campus’

Evotec SE announced the expansion of the Company’s existing campus based at Milton Park in Abingdon, Oxfordshire, UK, into a major, fully-integrated, co-located discovery and development centre to be named Dorothy Crowfoot Hodgkin Campus.

November 12, 2020
·
5 min read
Business

ONK Therapeutics Opens US R&D Operations and Appoints Head of R&D, USA

ONK Therapeutics, Inc. formed, to facilitate the expansion of operations in the USA, alongside its growing hub in Galway, Ireland

November 12, 2020
·
5 min read
Medidata and Oxford University Innovation’s Clinical Outcomes Team Announce Addition of Gold Standard Questionnaires to eCOA Library

Medidata and its customers gain access to pre-configured, pre-approved questionnaires in multiple languages to support clinical study start-up, quality, and efficiency

November 12, 2020
·
5 min read
Drug Development

AlzeCure receives approval to start clinical Phase I trial with ACD856 in Alzheimer’s disease

AlzeCure Pharma AB announced that the company has received approval from the regulatory authorities in Sweden to initiate a clinical Phase I study with the drug candidate ACD856.

November 12, 2020
·
5 min read
Business

iTeos Reports Third Quarter 2020 Financial Results and Provides Business Update

Patient enrollment in Phase 1/2 studies of EOS-850 A2AR antagonist and EOS-448 FCγR-enabled anti-TIGIT antibody continues with initial data expected in 1H21

November 12, 2020
·
9 min read
Bio NC

BioCryst to Present Data at the 2020 ASH Annual Meeting

BioCryst Pharmaceuticals, Inc. announced that preclinical data on BCX9930, an oral Factor D inhibitor, will be presented at the 62nd American Society of Hematology Annual Meeting being held as a virtual event, December 5-8, 2020.

November 12, 2020
·
4 min read
Nabriva Therapeutics to Participate in Upcoming Virtual Investor Conferences - Nov 12, 2020

Nabriva Therapeutics plc, a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced that management will participate in two upcoming investor conferences in November.

November 12, 2020
·
4 min read